Veracyte to Acquire HalioDx, Solidifying Global Leadership in Cancer Diagnostics Learn More
Veracyte to Acquire HalioDx, Solidifying Global Leadership in Cancer Diagnostics Learn More
Leadership
  • Marc Stapley
    Chief Executive Officer
    Marc Stapley
    Chief Executive Officer
    Mr. Stapley has deep experience in the genomic diagnostics industry, including significant expertise building and leading complex global operations.
    MORE ABOUT Marc >
  • Giulia C. Kennedy, Ph.D.
    Chief Scientific Officer and Chief Medical Officer
    Giulia C. Kennedy, Ph.D.
    Chief Scientific Officer and Chief Medical Officer
    Dr. Kennedy’s scientific leadership, Veracyte continually pushes the boundaries of what is possible in genomic diagnostics, using big data and machine learning to develop tests that answer critical clinical questions.
    MORE ABOUT Giulia >
  • James (Jim) Erlinger
    Executive Vice President, General Counsel and Secretary
    James (Jim) Erlinger
    Executive Vice President, General Counsel and Secretary
    Jim Erlinger is a seasoned attorney and business executive with 35 years of experience in the life sciences, pharmaceutical, drug development and healthcare industries.
    MORE ABOUT James (Jim) >
  • Tina S. Nova, Ph.D.
    General Manager, Thyroid & Urologic Cancers
    Tina S. Nova, Ph.D.
    General Manager, Thyroid & Urologic Cancers
    Tina S. Nova, Ph.D., serves as Veracyte’s general manager, Thyroid & Urology, leading the company’s flagship Afirma franchise in thyroid cancer and market-leading Decipher business in urologic cancers.
    MORE ABOUT Tina S. >
  • Morten Frost
    General Manager, Pulmonology & Breast Cancer
    Morten Frost
    General Manager, Pulmonology & Breast Cancer
    Morten Frost joined Veracyte in January 2021 as General Manager, Pulmonology & Breast Cancer, with global responsibility for strategic business planning and tactical execution, for the company’s lung cancer and interstitial lung disease (ILD) products.
    MORE ABOUT Morten >
  • Tracy Morris
    Vice President, Corporate Communications and Investor Relations
    Tracy Morris
    Vice President, Corporate Communications and Investor Relations
    In this role, she works in tandem with the Chief Executive Officer and executive team to communicate the company’s strategic vision and value proposition to investors and other audiences and ensures that the market-leading company’s brand is articulated in product and other communications.
    MORE ABOUT Tracy >